Pfizer Says Coronavirus Vaccine Is 95% Effective at the End of Its Trial
Last week, the drug maker made the groundbreaking announcement that it had created a vaccine that was 90 percent effective.

Reuters/Dado Ruvic
Get the Beast Digest newsletter delivered straight to your inbox
By clicking “SIGN UP” you agree to our Terms of Use and Privacy Policy.
Last week, the world erupted with joy at the news that Pfizer had developed a vaccine that appeared to be 90 percent effective. Now the drugmaker says its latest results show the vaccine is even better than it thought. According to The New York Times, the company said Wednesday that its vaccine is 95 percent effective and has no serious side effects. The conclusions are based on the drug maker’s first set of complete results from a late-stage vaccine trial. Crucially, the results showed the vaccine was 94 percent effective in older adults who are more vulnerable to succumbing to severe COVID-19 symptoms, and who sometimes don’t respond as strongly to some types of vaccinations. Pfizer, which developed the vaccine with its partner BioNTech, said it will apply to the Food and Drug Administration for emergency vaccine authorization “within days.”
Unlock a year of full access to The Daily Beast for $35.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Looks like you already have a subscription!
- Account (completed)
- Payment (completed)
- Confirmation (completed)
You're all set!
Thanks for subscribing.
- 1Account
- 2Payment
- 3Confirmation
Sign in or create an account
Register below to read this article for free or subscribe
to unlock unlimited access to The Daily Beast.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Already have an account? Sign In
Looks like you already have a subscription!
- Account (completed)
- Payment (completed)
- Confirmation (completed)
You're all set!
Thanks for subscribing.
- 1Account
- 2Payment
- 3Confirmation